• Paulien G Westhoff, Alexander de Graeff, Evelyn M Monninkhof, Laurens Bollen, Sander P Dijkstra, Elzbieta M van der Steen-Banasik, Marco van Vulpen, Jan Willem H Leer, Corrie A Marijnen, Yvette M van der Linden, and Dutch Bone Metastasis Study Group.
• Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: p.g.westhoff@umcutrecht.nl.
• Int. J. Radiat. Oncol. Biol. Phys. 2014 Nov 15; 90 (4): 739-47.

PurposePatients with bone metastases have a widely varying survival. A reliable estimation of survival is needed for appropriate treatment strategies. Our goal was to assess the value of simple prognostic factors, namely, patient and tumor characteristics, Karnofsky performance status (KPS), and patient-reported scores of pain and quality of life, to predict survival in patients with painful bone metastases.Methods And MaterialsIn the Dutch Bone Metastasis Study, 1157 patients were treated with radiation therapy for painful bone metastases. At randomization, physicians determined the KPS; patients rated general health on a visual analogue scale (VAS-gh), valuation of life on a verbal rating scale (VRS-vl) and pain intensity. To assess the predictive value of the variables, we used multivariate Cox proportional hazard analyses and C-statistics for discriminative value. Of the final model, calibration was assessed. External validation was performed on a dataset of 934 patients who were treated with radiation therapy for vertebral metastases.ResultsPatients had mainly breast (39%), prostate (23%), or lung cancer (25%). After a maximum of 142 weeks' follow-up, 74% of patients had died. The best predictive model included sex, primary tumor, visceral metastases, KPS, VAS-gh, and VRS-vl (C-statistic = 0.72, 95% CI = 0.70-0.74). A reduced model, with only KPS and primary tumor, showed comparable discriminative capacity (C-statistic = 0.71, 95% CI = 0.69-0.72). External validation showed a C-statistic of 0.72 (95% CI = 0.70-0.73). Calibration of the derivation and the validation dataset showed underestimation of survival.ConclusionIn predicting survival in patients with painful bone metastases, KPS combined with primary tumor was comparable to a more complex model. Considering the amount of variables in complex models and the additional burden on patients, the simple model is preferred for daily use. In addition, a risk table for survival is provided.Copyright © 2014 Elsevier Inc. All rights reserved.

24 keywords...

hide…